Study Purpose: This study will evaluate the efficacy and safety of study drug compared to placebo as adjunctive treatment in adult epilepsy subjects not fully controlled despite current treatment.
Basic Eligibility Criteria:
- Male and female patients between ages 16 and 80
- Well-characterized focal epilepsy/epileptic syndrome
|Clinical Trials: Current and Upcoming|
If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:
Patricia Mennona, Clinical Research Administrative Assistant at [email protected]
Clinical Research Coordinators:
Grace Valentin at mailto:[email protected]
Alicia Castelot at [email protected]
Kayla Kennedy at [email protected]
Lisa Lazarecki at [email protected]
Maxine Kuang at [email protected]
You may also call 203.333.1151 and we will be happy to answer any of your questions.